Zegocractin is under clinical development by CalciMedica and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia.

Diseases of the pancreas can mimic other medical conditions, and accurate diagnosis is crucial. With the increase in access ...

significantly reduces triglyceride levels in patients with severe hypertriglyceridemia (sHTG). The SHASTA-2 trial assessed ...

Pancreatitis in children, often mistaken for minor digestive issues, can cause severe abdominal pain and requires timely ...

The FDA has approved Zepbound, a weight-loss medication, as the first drug treatment for moderate to severe obstructive sleep ...

The US FDA has approved olezarsen (Tryngolza) as the first treatment for adults with familial chylomicronemia syndrome, a ...

US FDA approves Ionis Pharma’s Tryngolza to treat adults living with familial chylomicronemia syndrome as an adjunct to diet: Carlsbad, California Monday, December 23, 2024, 15: ...

Ionis Pharma's olezarsen has become the first FDA-approved drug therapy for adults with familial chylomicronaemia syndrome ...

A new prediction model for infected pancreatic necrosis (IPN) in patients with acute pancreatitis (AP) offers a groundbreaking approach to improving patient outcomes.

USA: A study published in Digestive and Liver Disease suggests that youths who experience acute pancreatitis may face an ...

The FDA approved olezarsen (Tryngolza) as the first drug for adults with familial chylomicronemia syndrome, a rare genetic ...